FDA Assigns Action Date of Jan 25, 2012 for Takeda’s Alogliptin

Takeda Global Research and Development Center, Inc (TGRD), a wholly-owned US subsidiary of Takeda Pharmaceutical, announced on November 1 that the US Food and Drug Administration (FDA) has assigned an action date of January 25, 2012, for the review of...read more